COMP <GO>
MANE vs GRFS // REVENUE GROWTH (YOY)
Veradermics Incorporated (NYSE) VS. Grifols S.A. (NASDAQ) • 15-METRIC TALLY: MANE 0
— GRFS 2
■ METRIC PARITY
LAST: $129.53 (-7.27%) • MKT CAP: $5.41B
revenue-growth
4.40%
LAST: $8.51 (+5.06%) • MKT CAP: $5.85B
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MANE VS. GRFS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MANE | GRFS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.90% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.19% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -4.30% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -4.20% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 4.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.9 | 75.1 | -25.20 | GRFS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.07 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.41B | $5.85B | -$439.3M | GRFS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MANE REV | GRFS REV | MANE GROSS % | GRFS GROSS % | MANE FCF | GRFS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $202.6M | — | — | — | -$71.6M | — |
| FY 2024 | $75.0M | — | — | — | -$23.7M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MANE // BETA 1.07
GRFS // BETA —